{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:42:04Z","timestamp":1762659724172},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bioorg.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T16:28:23Z","timestamp":1538670503000},"page":"123-128","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["3-Aminobenzenesulfonamides incorporating acylthiourea moieties selectively inhibit the tumor-associated carbonic anhydrase isoform IX over the off-target isoforms I, II and IV"],"prefix":"10.1016","volume":"82","author":[{"given":"Tanzeela Abdul","family":"Fattah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamer","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghulam","family":"Shabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.10.006_b0005","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2018.10.006_b0010","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/14756366.2012.736979","article-title":"Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro","volume":"28","author":"Gieling","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_b0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2018.10.006_b0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm901524f","article-title":"The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors","volume":"53","author":"Temperini","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_b0025","series-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","first-page":"139","article-title":"Antiglaucoma carbonic anhydrase inhibitors as ophthalomologic drugs","author":"Mincione","year":"2009"},{"key":"10.1016\/j.bioorg.2018.10.006_b0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_b0035","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.10.006_b0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1215\/15228517-2007-001","article-title":"Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy","volume":"9","author":"Haapasalo","year":"2007","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.bioorg.2018.10.006_b0045","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1016\/j.bmc.2015.05.019","article-title":"Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II IX and XII","volume":"23","author":"Ibrahim","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_b0050","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.bmc.2012.08.019","article-title":"Insights towards sulfonamide drug specificity in \u03b1-carbonic anhydrases","volume":"21","author":"Aggarwal","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_b0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2018.10.006_h0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Exp. Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.10.006_h0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/14756366.2014.910202","article-title":"An overview of the alpha-beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?","volume":"30","author":"Capasso","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?","volume":"33","author":"Supuran","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728222.2014.991312","article-title":"The eta-class carbonic anhydrases as drug targets for antimalarial agents","volume":"1","author":"Supuran","year":"2015","journal-title":"Exp. Opin. Ther. Targ."},{"issue":"Suppl. 4","key":"10.1016\/j.bioorg.2018.10.006_h0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/14756366.2016.1217856","article-title":"Cloning, expression and purification of the complete domain of the g-carbonic anhydrase from Plasmodium falciparum","volume":"31","author":"Del Prete","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0085","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bmc.2014.12.009","article-title":"Sulfonamide inhibition studies of theg-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum","volume":"23","author":"Vullo","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0095","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2018.10.006_h0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.10.006_h0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1568016043477305","article-title":"Designing of novel carbonic anhydrase inhibitors and activators","volume":"2","author":"Supuran","year":"2004","journal-title":"Curr. Med. Chem. Cardiovasc. Hematol. Agents"},{"key":"10.1016\/j.bioorg.2018.10.006_h0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0043-123998","article-title":"Synthesis and molecular docking studies of (E)-4-(substituted-benzylideneamino)-2H-chromen-2-one derivatives: entry to new carbonic anhydrase class of inhibitors","volume":"68","author":"Fattah","year":"2018","journal-title":"Drug Res."},{"key":"10.1016\/j.bioorg.2018.10.006_h0115","doi-asserted-by":"crossref","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2018.10.006_h0120","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0125","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm021123s","article-title":"Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanimamide and halogenophenylaminobenzolamide derivatives","volume":"46","author":"Ilies","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0130","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2018.10.006_h0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ctrv.2012.08.004","article-title":"New strategies for targeting the hypoxic tumour microenvironment in breast cancer","volume":"39","author":"Ward","year":"2013","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.bioorg.2018.10.006_h0140","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.10.006_h0145","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/jm031079w","article-title":"Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX","volume":"47","author":"Casey","year":"2004","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2018.10.006_b0080","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/S0960-894X(02)00475-4","article-title":"Parallel synthesis and anti-malarial activity of a sulfonamide library","volume":"12","author":"Ryckebusch","year":"2002","journal-title":"Bioorg. Medi. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2018.10.006_h0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1155\/MBD.2000.57","article-title":"Carbonic anhydrase inhibitors. Part 91. Metal complexes of heterocyclic sulfonamides as potential pharmacological agents in the treatment of gastric acid secretion imbalances","volume":"7","author":"Ilies","year":"2000","journal-title":"Met. Based Drugs"},{"key":"10.1016\/j.bioorg.2018.10.006_h0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/14756366.2015.1051042","article-title":"The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Pu\u015fca\u015f (1932\u20132015)","volume":"31","author":"Buz\u00e1s","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2018.10.006_b0090","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.bmcl.2008.09.030","article-title":"Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic\/heterocyclic sulfonamides\u2014in vitro and in vivo studies","volume":"18","author":"Krungkrai","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2018.10.006_b0095","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/EC.00266-07","article-title":"A chemogenomic screening of sulfanilamide-hypersensitive Saccharomyces cerevisiae mutants uncovers ABZ2, the gene encoding a fungal aminodeoxychorismate lyase","volume":"6","author":"Botet","year":"2007","journal-title":"Eukaryot. Cell."},{"issue":"8","key":"10.1016\/j.bioorg.2018.10.006_b0100","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1007\/s00044-012-0376-4","article-title":"Synthesis, molecular docking studies, and in vitro screening of sulfanilamide-thiourea hybrids as antimicrobial and urease inhibitors","volume":"22","author":"Saeed","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2018.10.006_b0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2014.03.023","article-title":"New aminobenzenesulfonamide\u2013thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies","volume":"78","author":"Zaib","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2018.10.006_b0110","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"issue":"sup2","key":"10.1016\/j.bioorg.2018.10.006_h0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14756366.2016.1187143","article-title":"A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents","volume":"31","author":"Diaz","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0195","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm050333c","article-title":"Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II","volume":"48","author":"Menchise","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0223-5234(98)80059-7","article-title":"Carbonic anhydrase inhibitors\u2014part 52. Metal complexes of heterocyclic sulfonamides: a new class of strong topical intraocular pressure-lowering agents in rabbits","volume":"33","author":"Supuran","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0205","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.10.006_h0210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1747-0285.2011.01104.x","article-title":"In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds","volume":"77","author":"\u015eent\u00fcrk","year":"2011","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.bioorg.2018.10.006_h0215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/14756366.2011.597749","article-title":"A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology","volume":"27","author":"Fabrizi","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0220","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/anie.201310709","article-title":"A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors","volume":"53","author":"Krall","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2018.10.006_h0225","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/14756360500141911","article-title":"In-vitro antibacterial, antifungal and cytotoxic activities of some coumarins and their metal complexes","volume":"20","author":"Rehman","year":"2005","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.006_h0230","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jps.2600830603","article-title":"Carbonic anhydrase activators. 3: structure-activity correlations for a series of isozyme II activators","volume":"83","author":"Clare","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2018.10.006_h0235","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","article-title":"Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation","volume":"99","author":"Dubois","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bioorg.2018.10.006_h0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1155\/MBD.2001.137","article-title":"Transition metal ion complexes of Schiff-bases. Synthesis, characterization and antibacterial properties","volume":"8","author":"Chohan","year":"2001","journal-title":"Met. Based Drugs"},{"key":"10.1016\/j.bioorg.2018.10.006_h0245","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/156802607780636753","article-title":"Inhibition of the archaeal \u03b2-class (Cab) and \u03b3-class (Cam) carbonic anhydrases","volume":"7","author":"Zimmerman","year":"2007","journal-title":"Curr. Top Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T08:47:23Z","timestamp":1662194843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818309283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":49,"alternative-id":["S0045206818309283"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.006","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-Aminobenzenesulfonamides incorporating acylthiourea moieties selectively inhibit the tumor-associated carbonic anhydrase isoform IX over the off-target isoforms I, II and IV","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}